GEG - NASDAQ
Great Elm Group, Inc.
$2.15
+2.3%Great Elm Group, Inc. engages in the durable medical equipment and investment management businesses. The company distributes respiratory care equipment, including positive air pressure equipment and supplies, ventilators and oxygen equipment, and replacement parts, as well as provides sleep study services; and rents medical equipment. It also offers investment management services. The company was formerly known as Great Elm Capital Group, Inc. and changed its name to Great Elm Group, Inc. in December 2020. Great Elm Group, Inc. was founded in 1994 and is headquartered in Waltham, Massachusetts.
At a Glance
Live Snapshotgeg
Cash and Short Term Investments
Last Annual Value
109.45M
3-Year CAGR
15%
5-Year CAGR
17%
10-Year CAGR
3%
Great Elm Group, Inc. Competitors Analysis of Cash and Short Term Investments
| Company | Cash and Short Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Great Elm Group, Inc. NASDAQ:GEG | 109.45M | -2.3% | 7.9% | 3.1% | |
 Assertio Holdings, Inc. NASDAQ:ASRT | 63.41M | -4.8% | 11.5% | -9.8% | |
 XBiotech Inc. NASDAQ:XBIT | 125.55M | -14.4% | -11.9% | 13.8% | |
 Pulmonx Corporation NASDAQ:LUNG | 70.01M | -15.8% | -17.2% | N/A | |
 Forian Inc. NASDAQ:FORA | 31.55M | -13.3% | 0.3% | N/A | |
 Spectral AI, Inc. NASDAQ:MDAI | 15.39M | 47.6% | -0.9% | N/A | |
 Artiva Biotherapeutics, Inc. NASDAQ:ARTV | 108.01M | 12.0% | -7.7% | N/A | |
 CAMP4 Therapeutics Corporation NASDAQ:CAMP | 109.52M | 41.8% | 3.7% | 0.9% | |
 Precision BioSciences, Inc. NASDAQ:DTIL | 115.58M | -0.3% | -4.3% | 2.2% | |
 Prelude Therapeutics Incorporated NASDAQ:PRLD | 103.21M | -23.8% | -18.7% | N/A | |
 Sutro Biopharma, Inc. NASDAQ:STRO | 141.43M | -27.8% | -6.5% | 11.5% |
Great Elm Group, Inc. Fair Value Envelope
Related Guides
Continue your GEG research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.